Professor Syed Hussain
Profiles

Professor Syed Hussain

Chair in Oncology

Institute of Translational & Stratified Medicine (Plymouth University Peninsula Schools of Medicine and Dentistry)

Role

Professor Syed A Hussain, MBBS, MSc, MD, FRCP

Professor and Chair in Oncology, Consultant in Medical Oncology. Plymouth University, Peninsula Schools of Medicine and Dentistry   

 

"Professor Hussain graduated from Dow Medical College Karachi in 1994. He completed his general medical professional training in UK. He did his Doctorate in Oncology from University of Birmingham. He then completed his Medical oncology training in Birmingham, United Kingdom and received his certification and specialist registration in Medical oncology.

He is Professor/ Chair and Consultant in Oncology at the University of Plymouth and Plymouth University Hospitals. His major areas of interest are management of urological cancers, clinical trials, early drug development and translational medicine. He has set up a large number of clinical trials from early phase to late phase studies during his career thus providing early access to novel drugs for patients within the region and receives patient referrals from far and wide.    

 

His work on organ preservation in bladder cancer moved all the way from an early phase I study (Hussain et al Annals of Oncology 2001), to phase II efficacy study (Hussain et al BJC 2004) that led to a Cancer Research UK funded study BC2001 trial that was reported in New England Journal of Medicine (James, Hussain, Hall et al April 2012). This study has now changed the standard of care for patients with muscle invasive bladder cancer opting for organ preservation treatment. His work on split dose cisplatin in bladder cancer has extended the spectrum of patients receiving cisplatin based chemotherapy (Hussain et al BJC 2004). Dr Hussain is principal investigator of a number of studies in bladder, prostate and kidney cancers. He is a chief investigator of a national randomised placebo-controlled phase II neo-adjuvant study in muscle invasive bladder cancer. He served as chief investigator of various early phase, and translational studies. Dr Hussain received prestigious ASCO merit award for two consecutive years.

 

 Dr Hussain has authored 77 peer-reviewed publications including 4 book chapters in textbooks of oncology. Dr Hussain has been an invited speaker to international and national meetings. Dr Hussain has secured funding of over 3.6 million pounds from national funding bodies.

Key publications are highlighted

Journals
Articles
Andronis L, Goranitis I, Pirrie S, Pope A, Barton D, Collins S, Daunton A, McLaren D, O'Sullivan JM & Parker C 2017 'Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)' BJU International 119, (4) 522-529 , DOI PEARL
Hussain S, Palmer D, Syn W-K, Sacco J, Greensmith R, Elmetwali T, Aachi V, Lloyd B, Jithesh P & Arrand J 2017 'Gene expression profiling in bladder cancer identifies potential therapeutic targets' International Journal of Oncology , DOI PEARL
Necchi A, Pond GR, Smaldone MC, Pal SK, Chan K, Wong Y-N, Viterbo R, Sonpavde G, Harshman LC & Crabb S 2017 'Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study' European Urology Focus , DOI
Choudhury A, West CM, Porta N, Hall E, Denley H, Hendron C, Lewis R, Hussain SA, Huddart R & James N 2017 'The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)' British Journal of Cancer 116, (5) 649-657 , DOI
Powles T, Wheater M, Din O, Geldart T, Boleti E, Stockdale A, Sundar S, Robinson A, Ahmed I & Wimalasingham A 2016 'A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer' European Urology 69, (3) 450-456 , DOI
El-Taji OMS, Alam S & Hussain SA 2016 'Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers' Current Treatment Options in Oncology 17, (3) , DOI
Locke JA, Pond GR, Sonpavde G, Necchi A, Giannatempo P, Paluri RK, Niegisch G, Albers P, Buonerba C & Di Lorenzo G 2016 'Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin' Clinical Genitourinary Cancer 14, (4) 331-340 , DOI
James ND, Pirrie SJ, Pope AM, Barton D, Andronis L, Goranitis I, Collins S, Daunton A, McLaren D & O’Sullivan J 2016 'Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both' JAMA Oncology 2, (4) 493-493 , DOI
Forootan FS, Forootan SS, Gou X, Yang J, Liu B, Chen D, Fayi MSA, Al-Jameel W, Rudland PS & Hussain SA 2016 'Fatty acid activated PPAR&#x03B3; promotes tumorigenicity of prostate cancer cells by up regulating <i>VEGF</i> via PPAR responsive elements of the promoter' Oncotarget 7, (8) 9322-9339 , DOI
Elander NO & Hussain SA 2016 'PARP Inhibition in Prostate Cancer: A Promising Approach' ONCOLOGY-NEW YORK 30, (5) 393-+ Author Site
Nedjadi T, Al-Ammari A, Khayyat D, Salem N, Al-Sayyad A, Hussain SA, Azhar E, Damanhouri G & Al-Maghrabi J 2016 'The cell cycle regulator p27(Kip1) is associated with urothelial bladder cancer invasion' INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 9, (10) 10515-10521 Author Site
Al Fayi MS, Gou X, Forootan SS, Al-Jameel W, Bao Z, Rudland PR, Cornford PA, Hussain SA & Ke Y 2016 'The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance' Oncotarget , DOI PEARL
Sharma S, Witteveen PO, Lolkema MP, Hess D, Gelderblom H, Hussain SA, Porro MG, Waldron E, Valera S-Z & Mu S 2015 'A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function' Cancer Chemotherapy and Pharmacology 75, (1) 87-95 , DOI
El-Taji O, Khattak A & Hussain S 2015 'Bladder reconstruction: The past, present and future (Review)' Oncology Letters , DOI
Necchi A, Pond GR, Giannatempo P, Di Lorenzo G, Eigl BJ, Locke J, Pal SK, Agarwal N, Poole A & Vaishampayan UN 2015 'Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy' Clinical Genitourinary Cancer 13, (2) 178-184 , DOI
Galsky MD, Pal SK, Chowdhury S, Harshman LC, Crabb SJ, Wong Y-N, Yu EY, Powles T, Moshier EL & Ladoire S 2015 'Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer' Cancer 121, (15) 2586-2593 , DOI
Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, Nava Rodrigues D, Robinson D, Omlin A & Tunariu N 2015 'DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer' New England Journal of Medicine 373, (18) 1697-1708 , DOI
Sundaram V, Hshieh T, Curry M, Kaung A & Hussain S 2015 'The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage' Saudi Journal of Gastroenterology 21, (4) 254-254 , DOI
Wang WJ, Gray S, Sison C, Arramraju S, John BK, Hussain SA, Kim SH, Mehta P & Rubin M 2014 'Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile -associated diarrhea' Therapeutic Advances in Gastroenterology 7, (1) 14-19 , DOI
Johnson PJ, Pirrie SJ, Cox TF, Berhane S, Teng M, Palmer D, Morse J, Hull D, Patman G & Kagebayashi C 2014 'The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers' Cancer Epidemiology Biomarkers & Prevention 23, (1) 144-153 , DOI
Hayden A, Douglas J, Sommerlad M, Andrews L, Gould K, Hussain S, Thomas GJ, Packham G & Crabb SJ 2014 'The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer' Urologic Oncology: Seminars and Original Investigations 32, (6) 806-814 , DOI
James ND & Hussain SA 2013 'A Multidisciplinary Approach in Muscle-Invasive Disease: Novel Chemotherapy Combinations and Targets in Chemoradiation' American Society of Clinical Oncology Educational Book 33, 200-206 , DOI
Gutkin E, Shalomov A, Hussain SA, Kim SH, Cortes R, Gray S, Judeh H, Pollack S & Rubin M 2013 'Pillcam ESO ® is more accurate than clinical scoring systems in risk stratifying emergency room patients with acute upper gastrointestinal bleeding' Therapeutic Advances in Gastroenterology 6, (3) 193-198 , DOI
Maughan BL, Agarwal N, Hussain SA, Boucher KM, Von Der Maase H, Kaufman DS, Lorusso V, Moore MJ, Galsky MD & Sonpavde G 2013 'Pooled Analysis of Phase II Trials Evaluating Weekly or Conventional Cisplatin as First-Line Therapy for Advanced Urothelial Carcinoma' Clinical Genitourinary Cancer 11, (3) 316-320 , DOI
Huddart RA, Hall E, Hussain SA, Jenkins P, Rawlings C, Tremlett J, Crundwell M, Adab FA, Sheehan D & Syndikus I 2013 'Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)' International Journal of Radiation Oncology*Biology*Physics 87, (2) 261-269 , DOI
Nici A, Hussain S, Rubin M & Kim S 2013 'Repair of a gastrocolic fistula using a wire-guided, simultaneous dual scope approach' Endoscopy 45, (S 02) E307-E308 , DOI
Palmer DH, Hussain SA, Smith AJ, Hargreaves S, Ma YT, Hull D, Johnson PJ & Ross PJ 2013 'Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom' British Journal of Cancer 109, (4) 888-890 , DOI
Hussain S 2012 'A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer' Oncology Letters , DOI
Gutkin E, Hussain SA & Kim SH 2012 'Changing angles: Successful treatment of superior mesenteric artery syndrome with double-balloon enteroscopy-assisted direct feeding jejunostomy' Digestive Endoscopy 24, (6) 482-482 , DOI
Gutkin E, Hussain SA & Kim SH 2012 'Ketamine-induced Biliary Dilatation' Journal of Addiction Medicine 6, (1) 89-91 , DOI
James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T & Hendron C 2012 'Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer' New England Journal of Medicine 366, (16) 1477-1488 , DOI
Gutkin E, Hussain SA & Kim SH 2012 'The Successful Treatment of Chronic Cholecystitis with SpyGlass Cholangioscopy-Assisted Gallbladder Drainage and Irrigation through Self- Expandable Metal Stents' Gut and Liver 6, (1) 136-138 , DOI
NICI ANTHONYJ, HUSSAIN SYEDA, KIM SANGH & MEHTA PREETI 2012 'UNIQUE USAGE OF A PARTIALLY COVERED METAL STENT FOR DRAINAGE OF A PANCREATIC PSEUDOCYST VIA ENDOSONOGRAPHY-GUIDED TRANSCYSTGASTROSTOMY' Digestive Endoscopy 24, (3) 185-187 , DOI
Bryan RT, Wei W, Shimwell NJ, Collins SI, Hussain SA, Billingham LJ, Murray PG, Deshmukh N, James ND & Wallace DMA 2011 'Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer' PROTEOMICS - Clinical Applications 5, (9-10) 493-503 , DOI
Ma YT, Cullen MH & Hussain SA 2011 'Biology of Germ Cell Tumors' Hematology/Oncology Clinics of North America 25, (3) 457-471 , DOI
Rubin M, Hussain SA, Shalomov A, Cortes RA, Smith MS & Kim SH 2011 'Live View Video Capsule Endoscopy Enables Risk Stratification of Patients with Acute Upper GI Bleeding in the Emergency Room: A Pilot Study' Digestive Diseases and Sciences 56, (3) 786-791 , DOI
Ansari J, A Hussain S, Alhasso A, Mahmood R, Ansari A & Glaholm J 2011 'Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions' Anti-Cancer Agents in Medicinal Chemistry 11, (3) 296-306 , DOI
Hassan MSU, Ansari J, Spooner D & Hussain SA 2010 'Chemotherapy for breast cancer (Review)' ONCOLOGY REPORTS 24, (5) 1121-1131 Author Site , DOI
2010 'Erratum' Hemodialysis International 14, (1) 152-152 , DOI
Ansari J, Glaholm J, McMenemin R, James ND & Hussain SA 2010 'Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma' Anti-Cancer Agents in Medicinal Chemistry 10, (3) 225-235 , DOI
Zeegers MP, Bryan RT, Langford C, Billingham L, Murray P, Deshmukh NS, Hussain S, James N, Wallace DMA & Cheng KK 2010 'The West Midlands Bladder Cancer Prognosis Programme: rationale and design' BJU International 105, (6) 784-788 , DOI
Chue AL, Fernando IN, Hussain SA & Yates DA 2009 'Chemotherapy related encephalopathy in a patient with Stage IV cervical carcinoma treated with cisplatin and 5-fluorouracil: a case report' Cases Journal 2, (1) 8526-8526 , DOI
Hussain SA, Esposito SP & Rubin M 2009 'Identification of Small Bowel Diverticula with Double-Balloon Enteroscopy Following Non-diagnostic Capsule Endoscopy' Digestive Diseases and Sciences 54, (10) 2296-2297 , DOI
HUSSAIN S, PIERING W, MOHYUDDIN T, SALEH M, ZHU Y-R, HANAN M & COHEN E 2009 'Outcome among patients with acute renal failure needing continuous renal replacement therapy: A single center study' Hemodialysis International 13, (2) 205-214 , DOI
Hussain SA & Cohen EP 2009 'Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study' Nephrology Dialysis Transplantation 24, (7) 2290-2290 , DOI
Ansari J, Palmer D, Rea D & Hussain S 2009 'Role of Tyrosine Kinase Inhibitors in Lung Cancer' Anti-Cancer Agents in Medicinal Chemistry 9, (5) 569-575 , DOI
Hussain SA, Palmer DH, Swinson DE, Riley P, Wills A, Brown C, Draycott C, El-Modir A, Peake DR & Rea DW 2008 'A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting' ONCOLOGY REPORTS 20, (1) 233-237 Author Site
Hussain SA, Ma YT, Palmer DH, Hutton P & Cullen MH 2008 'Biology of testicular germ cell tumors' Expert Review of Anticancer Therapy 8, (10) 1659-1673 , DOI
Hussain S, Pascoe J, Palmer D, Spooner D & Rea D 2008 'Genomics and Pharmacogenomics in the Management of Breast Cancer' Current Pharmacogenomics and Personalized Medicine 6, (1) 45-55 , DOI
Hussain SA, Ting Ma Y & Cullen MH 2008 'Management of metastatic germ cell tumors' Expert Review of Anticancer Therapy 8, (5) 771-784 , DOI
John BK, Dang NC, Hussain SA, Yang GCH, Cham MD, Yantiss R, Joseph AS, Giashuddin SM, Lee PC & Fleming R 2008 'Multifocal Granular Cell Tumor Presenting as an Esophageal Stricture' Journal of Gastrointestinal Cancer 39, (1-4) 107-113 , DOI
Gill JS, Hussain S, Rose C, Hariharan S & Tonelli M 2007 'Access to Kidney Transplantation among Patients Insured by the United States Department of Veterans Affairs' Journal of the American Society of Nephrology 18, (9) 2592-2599 , DOI
Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS & Billingham L 2007 'Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer' British Journal of Cancer 96, (1) 104-109 , DOI
Hussain SA, Palmer DH, Spooner D & Rea DW 2007 'Molecularly Targeted Therapeutics for Breast Cancer' BioDrugs 21, (4) 215-224 , DOI
Hussain SA, Rea DW & Palmer DH 2007 'Reply: Randomised studies with translational end points are required to further elucidate the prognostic and predictive value of CA IX' British Journal of Cancer 96, (8) 1310-1310 , DOI
Hussain S, Rea D, James N & Palmer D 2007 'Signal Transduction Therapy: Challenges to Clinical Trial Design' Current Signal Transduction Therapy 2, (1) 21-30 , DOI
Hussain SA & Hariharan S 2006 'BK virus infection after renal transplantation' Current Opinion in Organ Transplantation 11, (4) 413-417 , DOI
Vasudev B, Hariharan S, Hussain SA, Zhu Y-R, Bresnahan BA & Cohen EP 2005 'BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients' Kidney International 68, (4) 1834-1839 , DOI
Palmer DH, Hussain SA & Johnson PJ 2005 'Gene- and immunotherapy for hepatocellular carcinoma' Expert Opinion on Biological Therapy 5, (4) 507-523 , DOI
James N & Hussain SA 2005 'Management of muscle invasive bladder cancer - British approaches to organ conservation' SEMINARS IN RADIATION ONCOLOGY 15, (1) 19-27 Author Site , DOI
JAMES N & HUSSAIN S 2005 'Management of muscle invasive bladder cancer?British approaches to organ conservation' Seminars in Radiation Oncology 15, (1) 19-27 , DOI
HUSSAIN S & JAMES N 2005 'Molecular markers in bladder cancer' Seminars in Radiation Oncology 15, (1) 3-9 , DOI
Hussain SA & James ND 2005 'Molecular markers in bladder cancer' SEMINARS IN RADIATION ONCOLOGY 15, (1) 3-9 Author Site , DOI
Bryan RT, Hussain SA, James ND, Jankowski JA & Wallace DMA 2005 'Molecular pathways in bladder cancer: Part 1' BJU International 95, (4) 485-490 , DOI
Bryan RT, Hussain SA, James ND, Jankowski JA & Wallace DMA 2005 'Molecular pathways in bladder cancer: Part 2' BJU International 95, (4) 491-496 , DOI
Hussain S, Savin V, Piering W, Tomasi J & Blumenthal S 2005 'Phosphorus-enriched hemodialysis during pregnancy: Two case reports' Hemodialysis International 9, (2) 147-152 , DOI
Hussain SA, Palmer DH, Stevens A, Spooner D, Poole CJ & Rea DW 2005 'Role of chemotherapy in breast cancer' Expert Review of Anticancer Therapy 5, (6) 1095-1110 , DOI
Hussain SA, Stocken DD, Riley P, Palmer DH, Peake DR, Geh JI, Spooner D & James ND 2004 'A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer' British Journal of Cancer , DOI
Hussain SA, Palmer DH, Ganesan R, Hiller L, Gregory J, Murray PG, Pastorek J, Young L & James ND 2004 'Carbonic anhydrase IX, a marker of hypoxia: Correlation with clinical outcome in transitional cell carcinoma of the bladder' ONCOLOGY REPORTS 11, (5) 1005-1010 Author Site
Palmer DH, Hussain SA, Ganesan R, Cooke PW, Wallace DMA, Young LS & James ND 2004 'CD40 expression in prostate cancer: A potential diagnostic and therapeutic molecule' ONCOLOGY REPORTS 12, (4) 679-682 Author Site
Hussain SA, Palmer DH, Moon S & Rea DW 2004 'Endocrine therapy and other targeted therapies for metastatic breast cancer' Expert Review of Anticancer Therapy 4, (6) 1179-1195 , DOI
Hussain SA, Williams S, Stevens A & Rea DW 2004 'Endocrine therapy for early breast cancer' Expert Review of Anticancer Therapy 4, (5) 877-888 , DOI
Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DMA & James ND 2004 'Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer' British Journal of Cancer , DOI
Palmer DH, Hussain SA & Johnson PJ 2004 'Systemic therapies for hepatocellular carcinoma' Expert Opinion on Investigational Drugs 13, (12) 1555-1568 , DOI
Okorie MI, Hussain SA, Riley PL & McCafferty IJ 2004 'The use of self-expandable metal stents in the palliation of malignant bowel obstruction' ONCOLOGY REPORTS 12, (1) 67-71 Author Site
Hussain SA, Ganesan R, Hiller L, Cooke PW, Murray P, Young LS & James ND 2003 'BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder' ONCOLOGY REPORTS 10, (3) 571-576 Author Site
McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC & Franklyn JA 2003 'Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour' Clinical Endocrinology 58, (2) 141-150 , DOI
Simmons JL, Hussain SA, Riley P & Wallace DMA 2003 'Management of renal angiomyolipoma in patients with tuberous sclerosis complex' ONCOLOGY REPORTS 10, (1) 237-241 Author Site
Hussain SA, Ganesan R, Hiller L, Murray PG, El-Magraby MM, Young L & James ND 2003 'Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder' British Journal of Cancer 88, (4) 586-592 , DOI
Cohen EP, Hussain S & Moulder JE 2003 'Successful treatment of radiation nephropathy with angiotensin II blockade' International Journal of Radiation Oncology*Biology*Physics 55, (1) 190-193 , DOI
Hussain SA & James ND 2003 'The systemic treatment of advanced and metastatic bladder cancer' The Lancet Oncology 4, (8) 489-497 , DOI
Hussain SA & James ND 2002 'Organ preservation strategies in bladder cancer' Expert Review of Anticancer Therapy 2, (6) 641-651 , DOI
Hussain S, Bresnahan BA, Cohen EP & Hariharan S 2002 'Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents' Clinical Transplantation 16, (1) 43-47 , DOI
McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA & Gittoes NJL 2002 'Vascular Endothelial Growth Factor, Its Receptor KDR/Flk-1, and Pituitary Tumor Transforming Gene in Pituitary Tumors' The Journal of Clinical Endocrinology & Metabolism 87, (9) 4238-4244 , DOI
Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DMA & James ND 2001 'A phase I—II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer' Annals of Oncology 12, (7) 929-935 , DOI
Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P & Kerr DJ 2001 'Hepatocellular carcinoma' Annals of Oncology 12, (2) 161-172 , DOI
Mulholland PJ, Ferry DR, Anderson D, Hussain SA, Young AM, Cook JE, Hodgkin E, Seymour LW & Kerr DJ 2001 'Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin' Annals of Oncology 12, (2) 245-248 , DOI
Chung-Faye G, Palmer D, Anderson D, Clark J, Downes M, Baddeley J, Hussain S, Murray PI, Searle P & Seymour L 2001 'Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: A phase I and pharmacokinetic study of its prodrug, CB1954' CLINICAL CANCER RESEARCH 7, (9) 2662-2668 Author Site
Ansari 1994 'Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience' Oncology Reports 20, (4) , DOI
Ansari J, Hussain, Glaholm & Ansari A 0 'Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma' Biologics: Targets and Therapy 39-39 , DOI